
ANTIDIABETICS AND PANCREATIC ENZYMES
The manufacturers of acarbose and miglitol reasonably suggest that digestive enzyme preparations (such as amylase, pancreatin) would be expected to reduce the effects of these antidiabetics.
The manufacturers advise avoiding concurrent use.
The manufacturers advise avoiding concurrent use.